Stoxline.com
android_stock_chart
Stock Chart

Stoxline Lite

Stoxline Pro

Option Calculator
Stoxline
Mobile

Home | Charts | Showcases | Stock Ranks | Options | ETFs | Educations

 

7 Binary Options

 

Enter Stock Symbol:  

Cancer Genetics Inc (CGIX)

2.75 +0.05 (+1.85%)

10/20/2017  3:59pm

Open:

2.70

Pre. Close:

2.70

High:

2.75

Low:

2.65

Volume:

66,956

Market Cap:

54.42M

Stock Price Prediction (Update at 5:00pm est.)

If tomorrow:

Open lower

Open higher

High:

2.79 - 2.84

2.84 - 2.91

Low:

2.53 - 2.57

2.57 - 2.61

Close:

2.68 - 2.75

2.75 - 2.84

Technical analysis  (as of: 2017-10-20 4:34:36 PM)

Overall:

      

Stoxline posted a BUY today, upgraded from lower rating. This stock seems to be ready for a new bullish move. If you bought, continue to hold stock until SELL signal. You are relatively safe to buy now, a new upward move is expected.

Target:

Six months: 3.41     One year: 3.68

Support:

Support1: 2.55    Support2: 2.12

Resistance:

Resistance1: 2.92    Resistance2: 3.15

Pivot:

2.72

Moving Averages:

MA(5): 2.71     MA(20): 2.73

MA(100): 3.45     MA(250): 2.88

MACD:

MACD(12,26): -0.10     Signal(12,26,9): -0.12

%K %D:

%K(14,3): 47.62     %D(3): 44.44

RSI:

RSI(14): 42.59

52-Week:

High: 5.30  Low: 1.10  Change(%): 77.4

Average Vol(K):

3-Month: 10055  10-Days 2771

Strong Sell ★★ Sell ★★★ Neutral ★★★★ Buy ★★★★★ Strong Buy

Price, moving averages and Bollinger Bands

Price and moving averages has closed above its Short term moving average. Short term moving average is currently below mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is NEUTRAL in short-term; and BEARISH in mid-long term.
CGIX has closed below upper band by 34.0%. Bollinger Bands are 64.4% narrower than normal. The narrow width of the bands suggests low volatility as compared to CGIX's normal range. The bands have been in this narrow range for 9 bars. This is a sign that the market may be about to initiate a new trend.

Headline News

Fri, 29 Sep 2017 11:26:15 GMT
Cancer Genetics, Inc. to Present at The MicroCap Conference on October 5th in ...

Wed, 20 Sep 2017 13:18:45 GMT
Cancer Genetics, Inc. Announces 25th Contract Win to Provide Testing ...

Fri, 22 Sep 2017 12:11:15 GMT
Cancer Genetics, Inc. to Present at the 2017 Disruptive Growth Company ...

Wed, 13 Sep 2017 22:02:15 GMT
Analyzing Chemed Corp. (CHE) & Cancer Genetics (CGIX)

Thu, 27 Jul 2017 11:02:42 GMT
Cancer Genetics, Inc. Acclaimed by Frost & Sullivan For North American ...

Financial Analysis

Growth

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.

Profitability

Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.

Solvency

Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.

Efficiency

Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.

Click here to get more fundamental analysis.

 

Free Technical Analysis Charts

Stock Basics & Statistics

Sector:  Healthcare

Industry:  Healthcare Facilities Services

Shares Out. (M)

Shares Float (M)

13.88

% Held by Insiders

20.23

% Held by Institutions

16.23

Shares Short (K)

1800

Shares Short Prior Month (K)

1920

Stock Financials

EPS

-1.020

EPS Est. Current Year

-0.860

EPS Est. Next Year

-0.170

EPS Est. Next Quarter

-0.100

Forward EPS

-0.170

Book Value (p.s.)

0.940

PEG Ratio

-0.08

Profit Margin

-68.48

Operating Margin

-48.84

Return on Assets (ttm)

-19.7

Return on Equity (ttm)

-79.0

Qtrly Rev. Growth

-5.7

Gross Profit (p.s.)

0.411

Sales Per Share

EBITDA (p.s.)

-0.460

Qtrly Earnings Growth

Operating Cash Flow (M)

-12.64

Levered Free Cash Flow (M)

-8.12

FoxReading.com

Valuation

P/E

-2.70

P/E Growth Ratio

0.02

P/BV

2.93

P/S

44627520.00

P/CF

Dividend Yield

Dividends & Splits

Dividend

Dividend Pay Date

Invalid DateTime.

Ex-Dividend Date

Invalid DateTime.

Forward Dividend

Last Split Date

Last Split Ratio

-1e+010

 

(c) 2006-2017 Stoxline.com | Contact us | NYSE, NASDAQ, AMEX Stock symbols

Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.